{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:16:21Z","timestamp":1780676181162,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,2]]},"DOI":"10.7759\/cureus.14265","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T01:28:00Z","timestamp":1617413280000},"source":"Crossref","is-referenced-by-count":9,"title":["Mortality in Acromegalic Patients: Etiology, Trends, and Risk Factors"],"prefix":"10.7759","author":[{"given":"Fatmah S","family":"Alhawyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2007.10.002","article-title":"Acromegaly","volume":"37","author":"Ben-Shlomo A","year":"2008","unstructured":"Ben-Shlomo A, Melmed S. Acromegaly. Endocrinol Metab Clin North Am. 2008, 37:101-122. 10.1016\/j.ecl.2007.10.002","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao A","year":"2019","unstructured":"Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P, Pereira AM, Pivonello R. Acromegaly. Nat Rev Dis Primers. 2019, 5:20. 10.1038\/s41572-019-0071-6","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03626.x","article-title":"Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed","volume":"72","author":"Reid TJ","year":"2010","unstructured":"Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf). 2010, 72:203-208. 10.1111\/j.1365-2265.2009.03626.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal J","year":"2016","unstructured":"Dal J, Feldt-Rasmussen U, Andersen M, et al.. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. Eur J Endocrinol. 2016, 175:181-190. 10.1530\/eje-16-0117","journal-title":"Eur J Endocrinol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0655-4","article-title":"The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013","volume":"18","author":"Hoskuldsdottir GT","year":"2015","unstructured":"Hoskuldsdottir GT, Fjalldal SB, Sigurjonsdottir HA. The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013. Pituitary. 2015, 18:803-807. 10.1007\/s11102-015-0655-4","journal-title":"Pituitary"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao A","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev. 2004, 25:102-152. 10.1210\/er.2002-0022","journal-title":"Endocr Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-017-0797-7","article-title":"Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities","volume":"20","author":"Pivonello R","year":"2017","unstructured":"Pivonello R, Auriemma RS, Grasso LF, et al.. Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities. Pituitary. 2017, 20:46-62. 10.1007\/s11102-017-0797-7","journal-title":"Pituitary"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0758-6","article-title":"Acromegalic osteopathy","volume":"20","author":"Mazziotti G","year":"2017","unstructured":"Mazziotti G, Maffezzoni F, Frara S, Giustina A. Acromegalic osteopathy. Pituitary. 2017, 20:63-69. 10.1007\/s11102-016-0758-6","journal-title":"Pituitary"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado M","year":"2014","unstructured":"Mercado M, Gonzalez B, Vargas G, et al.. Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab. 2014, 99:4438-4446. 10.1210\/jc.2014-2670","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2675","article-title":"Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort","volume":"100","author":"dos Santos Silva CM","year":"2015","unstructured":"dos Santos Silva CM, Gottlieb I, Volschan I, et al.. Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort. J Clin Endocrinol Metab. 2015, 100:4447-4455. 10.1210\/jc.2015-2675","journal-title":"J Clin Endocrinol Metab"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1530\/eje-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione L","year":"2017","unstructured":"Maione L, Brue T, Beckers A, et al.. Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry. Eur J Endocrinol. 2017, 176:645-655. 10.1530\/eje-16-1064","journal-title":"Eur J Endocrinol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1530\/eje-12-0084","article-title":"Predictors of morbidity and mortality in acromegaly: an Italian survey","volume":"167","author":"Arosio M","year":"2012","unstructured":"Arosio M, Reimondo G, Malchiodi E, et al.. Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol. 2012, 167:189-198. 10.1530\/eje-12-0084","journal-title":"Eur J Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson L","year":"2014","unstructured":"Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA. Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014, 99:3933-3951. 10.1210\/jc.2014-2700","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/342034","article-title":"Results of gamma knife radiosurgery in acromegaly","volume":"2012","author":"Franzin A","year":"2012","unstructured":"Franzin A, Spatola G, Losa M, Picozzi P, Mortini P. Results of gamma knife radiosurgery in acromegaly. Int J Endocrinol. 2012, 2012:342034. 10.1155\/2012\/342034","journal-title":"Int J Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1530\/eje-13-1022","article-title":"Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)","volume":"171","author":"Colao A","year":"2014","unstructured":"Colao A, Vandeva S, Pivonello R, et al.. Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy). Eur J Endocrinol. 2014, 171:263-273. 10.1530\/eje-13-1022","journal-title":"Eur J Endocrinol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1530\/erc-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen E","year":"2016","unstructured":"Ritvonen E, L\u00f6yttyniemi E, Jaatinen P, et al.. Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer. 2016, 23:469-480. 10.1530\/erc-16-0106","journal-title":"Endocr Relat Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/eje-13-0166","article-title":"Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study","volume":"169","author":"Bogazzi F","year":"2013","unstructured":"Bogazzi F, Colao A, Rossi G, et al.. Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study. Eur J Endocrinol. 2013, 169:367-376. 10.1530\/eje-13-0166","journal-title":"Eur J Endocrinol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha MR","year":"2019","unstructured":"Gadelha MR, Kasuki L, Lim DST, Fleseriu M. Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev. 2019, 40:268-332. 10.1210\/er.2018-00115","journal-title":"Endocr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock M","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA, et al.. ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab. 2009, 94:4216-4223. 10.1210\/jc.2009-1097","journal-title":"J Clin Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1530\/eje-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito D","year":"2018","unstructured":"Esposito D, Ragnarsson O, Granfeldt D, Marlow T, Johannsson G, Olsson DS. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study. Eur J Endocrinol. 2018, 178:459-469. 10.1530\/eje-18-0015","journal-title":"Eur J Endocrinol"},{"key":"ref21","article-title":"Mortality in acromegaly","volume":"39","author":"Wright AD","year":"1970","unstructured":"Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med. 1970, 39:1-16.","journal-title":"Q J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb03135.x","article-title":"Epidemiology of acromegaly in the Newcastle region","volume":"12","author":"Alexander L","year":"1980","unstructured":"Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf). 1980, 12:71-79. 10.1111\/j.1365-2265.1980.tb03135.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly","volume":"41","author":"Rajasoorya C","year":"1994","unstructured":"Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK. Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf). 1994, 41:95-102. 10.1111\/j.1365-2265.1994.tb03789.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1530\/eje-08-0267","article-title":"A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly","volume":"159","author":"Holdaway IM","year":"2008","unstructured":"Holdaway IM, Bolland MJ, Gamble GD. A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. Eur J Endocrinol. 2008, 159:89-95. 10.1530\/eje-08-0267","journal-title":"Eur J Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers OM","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab. 2008, 93:61-67. 10.1210\/jc.2007-1191","journal-title":"J Clin Endocrinol Metab"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-015-0700-3","article-title":"The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study","volume":"19","author":"Varadhan L","year":"2016","unstructured":"Varadhan L, Reulen RC, Brown M, Clayton RN. The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study. Pituitary. 2016, 19:251-261. 10.1007\/s11102-015-0700-3","journal-title":"Pituitary"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000375163","article-title":"Treatment factors that influence mortality in acromegaly","volume":"103","author":"McCabe J","year":"2016","unstructured":"McCabe J, Ayuk J, Sherlock M. Treatment factors that influence mortality in acromegaly. Neuroendocrinology. 2016, 103:66-74. 10.1159\/000375163","journal-title":"Neuroendocrinology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031584","article-title":"Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly","volume":"89","author":"Ayuk J","year":"2004","unstructured":"Ayuk J, Clayton RN, Holder G, Sheppard MC, Stewart PM, Bates AS. Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab. 2004, 89:1613-1617. 10.1210\/jc.2003-031584","journal-title":"J Clin Endocrinol Metab"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway IM","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD. Factors influencing mortality in acromegaly. J Clin Endocrinol Metab. 2004, 89:667-674. 10.1210\/jc.2003-031199","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2450","article-title":"A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk","volume":"99","author":"Sherlock M","year":"2014","unstructured":"Sherlock M, Reulen RC, Aragon-Alonso A, et al.. A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk. J Clin Endocrinol Metab. 2014, 99:478-485. 10.1210\/jc.2013-2450","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55371-mortality-in-acromegalic-patients-etiology-trends-and-risk-factors","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:51Z","timestamp":1707507111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55371-mortality-in-acromegalic-patients-etiology-trends-and-risk-factors"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.14265","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,2]]}}}